Table 3
Review | Phase 2 | Phase 3 | |||
---|---|---|---|---|---|
1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | 5. Risk of bias in the review | |
Multiple CAM therapies | |||||
1. Perry [22] | Low | Unclear | Low | Low | Low |
2. Bruyas-Bertholon [23] | High | High | Unclear | High | High |
3. Harb [24] | High | High | Low | High | High |
4. Gutierrez-Castrellon [25] | Unclear | High | High | High | High |
Manipulation therapies | |||||
5. Dobson [26] | Low | Low | Low | Low | Low |
6. Gleberzon [27] | High | High | Unclear | Unclear | High |
7. Carnes [28] | Low | Low | Low | High | Unclear |
Acupuncture | |||||
8. Skejeie [29] | Low | Low | Low | Low | Unclear |
Herbal medicine | |||||
9. Anheyer [30] | Unclear | High | Low | High | High |
Probiotics | |||||
10. Sung [31] | Unclear | Low | Low | High | Unclear |
11. Anabrees [32] | Low | Low | Low | High | Low |
12. Urbanska [33] | Low | High | High | High | High |
13. Xu [34] | Unclear | Low | Low | Unclear | Low |
14. Shreck Bird [35] | High | High | Low | High | High |
15. Dryl [36] | High | High | Unclear | High | High |
16. Sung [37] | High | Unclear | Unclear | Unclear | Unclear |